First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging - Company Positioned for U.S. Commercial Launch in a Growing Intravascular Imaging Market Estimated at Over $1 Billion ...

The TAG Award recognizes companies that are advancing innovation and driving meaningful progress within the healthcare sector. Conavi’s hybrid intravascular imaging platform represents a ...

TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, ...

TORONTO--(BUSINESS WIRE)--Conavi Medical Inc. (www.conavi.com), a leader of hybrid imaging guidance for common minimally invasive heart procedures, has entered into agreements for over $20 million in ...

TORONTO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (CNVI:CA) (“Conavi Medical” or the “Company”), a commercial stage company focused on designing, manufacturing, and marketing imaging ...

Conavi Medical is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid™ System is the ...

TORONTO--(BUSINESS WIRE)--Conavi TM Medical Inc. (www.conavi.com) is pleased to announce the first clinical use of the Novasight TM Hybrid System, which enables ...

- Merger to create publicly-listed, commercial-stage leader in hybrid intravascular imaging - “This planned merger comes at a pivotal moment in the evolution of our company as we continue to advance ...

Leadership Team Expanded to Support U.S. Commercial Launch and Operational Scale-Up Company Advances Manufacturing, Conference Visibility, and Launch Readiness TORONTO, Dec. 29, 2025 (GLOBE NEWSWIRE) ...

TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (CNVI:CA) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, ...

– Completed US$7.7 million financing and reverse takeover to take Company public – Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million payment, ...